Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

Eli Lilly HQ

Lilly and Incyte’s baricitinib aces phase III trials

Supports its potential as a therapy for rheumatoid arthritis

- PMLiVE

Patients ‘sceptical’ about biosimilars, says EULAR

Concerns for safety of drugs for arthritis and other musculoskeletal diseases

- PMLiVE

Kantar Health promotes Jade Cusick to chief client officer

Cusick will head the firm’s new global client consulting group

- PMLiVE

J&J and LDC to join forces on unmet medical needs

Collaboration will aim to find and accelerate new potential treatments

- PMLiVE

Bayer sells diabetes division to Panasonic Healthcare

€1.02bn sale includes Contour electronic meters and other medical devices

- PMLiVE

Praluent and Repatha backed for approval in US

Sanofi and Amgen remain in fierce competition in PCSK9 inhibitors

- PMLiVE

Just manufacturing pills ‘no longer good enough for patients’

Pharma must truly move beyond the pill and embrace digital health, according to industry heads

- PMLiVE

Clark Health Communications make three team additions

Announcements coincides with its Communiqué Awards nominations

- PMLiVE

Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance

- PMLiVE

MRC Technology and Peptinnovate join on bone disease

Firms aim to discovery a therapy using natural peptides 

EISAI

Eisai launches thyroid cancer therapy Lenvima in UK

The UK is its first European market, with wider EU roll out expected in coming months

- PMLiVE

Receptos rejected AZ takeover bid, say sources

Sources also claim the Delaware-based firm is being chased by Gilead Sciences and Teva

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links